Canada markets closed

Nestlé S.A. (0QR4.L)

LSE - LSE Delayed Price. Currency in CHF
Add to watchlist
115.24+0.78 (+0.68%)
At close: 07:40AM GMT
Full screen
Previous Close114.46
Open114.84
BidN/A x N/A
AskN/A x N/A
Day's Range114.24 - 115.24
52 Week Range90.70 - 120.00
Volume8,211
Avg. Volume1,173,134
Market CapN/A
Beta (5Y Monthly)0.28
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters

    UPDATE 2-Skin care company Galderma announces price range for $2.6 bln flotation

    Skincare company Galderma was on course to raise 2.3 billion ($2.6 billion) Swiss francs from its upcoming initial public (IPO) offering after a positive response from potential investors. The company, whose products includes Cetaphil, a product for damaged and sensitive skin, as well as fillers and skin creams, early on Wednesday announced a price range of 49 to 53 Swiss francs for its flotation - likely to be one of the biggest in Europe this year. The offering consists of up to 40.5 million new shares and 277,000 existing shares, the company said.

  • Yahoo Finance UK

    Chocolate Easter egg prices set to rise as cost of cocoa surges

    Latest surge in world cocoa prices means bad news for Easter egg hunters.

  • Yahoo Finance Video

    Where Nestle sees opportunity in the weight-loss drug craze

    There have been some fears that GLP-1 weight-loss drugs could cause a decline in snack food sales. But European food giant Nestlé (NSRGY, NESN.SW) sees a unique opportunity. CEO Mark Schneider says the company's nutrition products could help those who use medications like Ozempic and Wegovy, who may need foods with additional nutritional benefits. Yahoo Finance's Josh Schafer, Brooke DiPalma, and Pras Subramanian discuss the comments in the video above. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Stephanie Mikulich